Today $NTLA will present its first preclinical data set on its novel cytosine deaminase #baseeditor technology at the 7th @CSHL meeting on Nucleic Acid Therapies. Full details here: https://t.co/VQ3JPYUAjn #cshlNAT #genomeediting https://t.co/eV1MDH84rE